Life Technologies to Redeem $350M in Senior Notes | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Life Technologies said after the close of the market Wednesday that it plans to redeem all of the outstanding 2 percent convertible senior notes due 2023.

The firm said that as of June 30, there was $349,544,000 in aggregate principal amount of the notes outstanding. The notes are convertible any time before 5:00 PM Eastern Time on Aug. 5, 2010, at a rate of 29.3094 shares of common stock per $1,000 principal amount of the notes surrendered.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: cell-free DNA from tumors is shorter than DNA from healthy cells, type 2 diabetes-related loci, and more.

Genetic analysis confirms that blood found on leaves collected near Marche-les-Dames some 80 years ago belongs to King Albert I of Belgium.

Researchers in the US begin to seek participants for the 1 million-person precision medicine cohort, the New York Times reports.

A new report indicates that women are underrepresented among US patent holders.